Yu-Waye Chu, Chief Medical Officer at FATE THERAPEUTICS INC (FATE), sold 2,532 shares at $6.52 ($17K) on 2023-04-18, disclosed to the SEC on 2023-04-19.
Open-market sale of $17k FATE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.52 | 215 | $1K | 8.4% |
| 2 | $6.58 | 2,317 | $15K | 91.6% |
| Total | $6.57 avg | 2,532 | $17K | 100% |
| Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |
| FATE | SELL | 2022-01-13 | $364K | — | Filing → |